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 Analytical method was developed for the estimation of Brexpiprazole drug substance by 
liquid chromatography. The chromatographic separation was achieved on C18 column 
(Inertsil ODS 3V 150*4.6, 5um) at ambient temperature .the separation achieved employing a 
mobile phase consists of 0.1%v/v Formic acid in water: Methanol (35:65). The flow rate was 
0.8 ml/ minute and ultra violet detector at 315nm. The average retention time for 
Brexpiprazole found to be 2.27 min the proposed method was validated for selectivity, 
precision, linearity and accuracy. All validation parameters were within the acceptable range. 
The assay methods were found to be linear from 50-150µg/ml for Brexpiprazole. 
Please cite this article in press as Dr Challa Sudheer et al. Method Development and Validation for the Estimation of 
Brexpiprazole in Drug Substance by RP-HPLC Method. Indo American Journal of Pharmaceutical Research.2017:7(05). 
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INTRODUCTION 
Brexpiprazole is an antipsychotic medication. It works by changing the actions of chemicals in the brain. Brexpiprazole is 
used to treat the symptoms of schizophrenia. It is also used together with other medications to treat major depressive disorder in 
adults. Brexpiprazole is a novel D2 dopamine and serotonin 1A partial agonist, called serotonin-dopamine activity modulator 
(SDAM), and a potent antagonist of serotonin 2A receptors, noradrenergic alpha 1B and 2C receptors. 
Brexpiprazole is chemically designated as 7-{4-[4-(1-benzothiophen-4-yl) piperazin-1-yl]butoxy}-1,2-dihydroquinolin-2-
one. Its molecular formula is C25H27N3O2S, and its molecular weight is 433.57. Brexpiprazole is a white-to-off white powder. It is 
freely soluble in methanol and practically insoluble in water
.
. 
 
 
 
Structure of Brexpiprazole. 
 
EXPERIMENTAL: 
Equipments: 
The chromatographic technique performed on a waters 2695 with 2487 detector  and Empower2 software, reversed phase 
C18 column (Inertsil 5µ, 150 mm × 4.6 mm) as stationary phase ,Ultrasonic cleaner, Scaletech analytical balance ,Vaccum micro 
filtration unit with 0.45µ membrane filter was used in the study. 
 
Materials:  
Pharmaceutically pure sample of Brexpiprazole were obtained as gift samples from Fortune pharma training institute, sri sai 
nagar, KPHB and Hyderabad, India.    
HPLC-grade Methanol was from qualigens reagents pvt ltd. Formic acid (AR grade) was from sd fine chem.  
 
Chromatographic conditions 
The sample separation was achieved on a C18 (5 μ, 15 cm Χ 4.6 mm i.d.) INERTSIL column, aided by mobile phase mixture 
of 0.1%v/v formic acid in water: Methanol (35:65). The flow rate was 0.8 ml/ minute and ultra violet detector at 315nm that was 
filtered and degassed prior to use, Injection volume is 10 μl and ambient temperatures. 
 
Preparation of mobile phase:  
Buffer Preparation: 
Take accurately 1ml of formic acid in 1000mL of water  
 
Mobile phase: 
Then add 35 volumes of buffer and 65 volumes of Methanol mixed well and sonicated for 5 min. 
 
Preparation of standard stock solution: 
A 50mg of pure Brexpiprazole were weighed and transferred to 50 ml of volumetric flask and dissolved in methanol. The 
flask was shaken and volume was made up to mark with methanol to give a primary stock solution containing 1000µg/ml. From the 
above solution 1ml of solution is pipette out into a 10 ml volumetric flask and volume was  made up to mark with methanol  to give a 
solution containing 100µg/ml of Brexpiprazole. 
 
Preparation of sample solution: 
A 50mg of Brexpiprazole sample were weighed and transferred to 50 ml of volumetric flask and dissolved in methanol. The 
flask was shaken and volume was made up to mark with methanol to give a primary stock solution containing 1000µg/ml. From the 
above solution 1ml of solution is pipette out into a 10 ml volumetric flask and volume was  made up to mark with methanol  to give a 
solution containing 100µg/ml of Brexpiprazole. 
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RESULTS AND DISCUSSIONS: 
Determination Of Working Wavelength (λ max): 
10 mg of the Brexpiprazole standard drug is taken in a 10 ml volumetric flask and dissolved in methanol and volume made 
up to the mark, from this solution 0.1ml is pipetted into 10 ml volumetric flask and made upto the mark with the methanol to give a 
concentration of 10 µg/ml.  The above prepared solution is scanned in uv between 200-400 nm using methanol as blank. The λmax 
was found to be 315nm 
After several initial trails with mixtures of methanol, water, ACN and buffers in various combinations and proportions, a trail 
with a mobile phase mixture of 0.1%v/v Formic acid in water: Methanol (35:65). The flow rate was 0.8 ml/ minute brought sharp 
peaks. The chromatogram was shown in Figure-1. 
 
 
 
Figure: 1 Chromatogram of Brexpiprazole. 
 
METHOD VALIDATION 
 
Linearity: 
Linearity was studied by analyzing five standard solutions covering the range of 50-150 µg/ml of Brexpiprazole. From the 
primary stock solution 0.5ml,0.75ml,1.0ml,1.25ml,1.5 ml of solution pipette into 10 ml volumetric flasks individually and made up to 
the mark with methanol to give a concentrations of  50µg/mL , 75µg/mL ,100µg/mL ,125µg/mL and 150 µg/mL of Brexpiprazole  . 
Calibration curve with concentration verses peak areas was plotted by injecting the above prepared solutions  and the 
obtained data were subjected to regression analysis using the least squares method. 
 
Table No: 1. 
 
Level Concentration (mg/mL) Peak area 
50% 0.05 1477294 
75% 0.075 2265508 
100% 0.10 3000811 
125% 0.125 3658939 
150% 0.150 4425025 
 
 
 
FigureNo.2: Linearity (calibration) curve of Brexpiprazole. 
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Limit of detection and limit of quantification: 
The limit of detection (LOD) and limit of quantification (LOQ) were separately determined based on standard deviation of 
the y-intercept and the slope of the calibration curve by using the equations (3) and (4), respectively.   
 
LOD = 3.3 δ/S ………. (3) 
 
LOQ =10 δ/S ……….. (4) 
Where,               
σ = the standard deviation of the response         
S = the slope of the calibration curve  
The slope S may be estimated from the calibration curve of the analyte.  
 
Table no.2: LOD and LOQ values Calculated from calibration curve: 
 
  mg 
LOQ 0.013 
LOD 0.004 
 
Method precision (repeatability)  
The precision of the instrument was checked by repeated injections and measurement of peak areas and retention times of 
solutions (n = 6) for, 100 µg/ml of BREXPIPRAZOLE without changing the parameter of the proposed chromatographic method. 
 
Table.3: Summary of peak areas for method precision. 
 
Sample No Retention time Peak area % Assay 
1 2.219 2982351 100.6 
2 2.220 2988289 100.8 
3 2.220 2939752 99.1 
4 2.218 2995127 101.0 
5 2.219 2984599 100.6 
6 2.220 2996062 101.0 
Mean 2.22 2981030 100.5 
%RSD 0.04 0.70 0.71 
 
Accuracy (recovery study):  
The accuracy of the method was determined by calculating the recoveries of BREXPIPRAZOLE by analyzing solutions 
containing approximately 50%, 100% and 150% of the working strength of Brexpiprazole. The percentage recovery results obtained 
are listed in Table 4 
 
Table No.4: Accuracy data. 
 
LEVEL S.No %Recovery of BREXPIPRAZOLE  Average 
50 1 98.8 99.2% 
2 99.6 
3 99.2 
100 1 100.6 100.2% 
2 100.8 
3 99.1 
150 1 99.1 99.2% 
2 100.2 
3 99.6 
 
ROBUSTNESS 
Robustness is the measure of a method remain unaffected by small, deliberate changes in method parameters like flow rate 
and detection wavelength on assay of the analyte of interest. Here the detection wavelength varied ±2nm and flow rate was varied ±0.1 
ml/min. The results were shown in (Table no.5). 
 
Ruggedness: 
The ruggedness of the method was studied by analyzing the sample and standard preparations by two analysts. The %RSD 
assay values between two analysts was calculated i.e., (limit <2%). 
This indicates the method was rugged. The results were shown in Table no.6. 
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Table No.5: Results of Robustness study. 
 
Parameter Rt of BREXPIPRAZOLE Theoretical plates Asymmetry 
Decreased flow  rate (0.7ml/min) 2.653 2260 1.31 
Increased flow rate (0.9ml/min) 1.907 1884 1.29 
Wave Length 313nm 2.219 2107 1.30 
317 2.219 2126 1.31 
 
Table No.6: Results of Ruggedness. 
 
  %Assay %RSD 
Analyst-1 BREXPIPRAZOLE 100.6 0.14% 
Analyst-2 100.8 
 
Table No.7: Validation parameters of evaluated method: 
 
S. No Parameter Limit Value Obtained 
1 Linearity concentrations Range  (mg/mL) 
Correlation coefficient 
NLT 0.990 0.05 to 0.15 mg\ml  
0.9996 
2 Method precision 
(Repeatability) 
(%RSD, n = 6) 
98.0 to 102.0 % 99.1 to 101.0 % 
3 ACCURACY(%Recovery) 98-102% 98.8 to 100.8%  
4. Robustness 
 
It should be meet  
System suitability criteria 
Complies 
Flow Variation(0.7mL to 0.9 mL/min) 
Wavelength Variation 
(313nm to 317nm) 
5. Ruggedness 
(Intermediate Precision) (%RSD analyst to analyst variation) 
NMT 2% 0.14% 
*RSD = Relative standard deviation. 
 
CONCLUSION 
From the above experimental results and parameters it was concluded that, this newly developed method for the estimation of 
BREXPIPRAZOLE was found to be simple, precise, accurate and high resolution and shorter retention time makes this method more 
acceptable and cost effective and it can be effectively applied for routine analysis in research institutions, quality control department in 
meant in industries and approved testing laboratories. 
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